Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

PROCEPT BioRobotics (PRCT) Shares Issued (2020 - 2026)

PROCEPT BioRobotics has reported Shares Issued over the past 7 years, most recently at $222000.0 for Q1 2026.

  • Quarterly Shares Issued fell 82.9% to $222000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Mar 2026, down 61.63% year-over-year, with the annual reading at $4.8 million for FY2025, 56.38% down from the prior year.
  • Shares Issued was $222000.0 for Q1 2026 at PROCEPT BioRobotics, down from $1.6 million in the prior quarter.
  • Over five years, Shares Issued peaked at $160.2 million in Q4 2023 and troughed at -$1.3 million in Q3 2022.
  • The 5-year median for Shares Issued is $1.3 million (2022), against an average of $11.8 million.
  • Year-over-year, Shares Issued crashed 250.23% in 2022 and then soared 35750.0% in 2023.
  • A 5-year view of Shares Issued shows it stood at -$1.3 million in 2022, then soared by 12528.08% to $160.2 million in 2023, then tumbled by 97.75% to $3.6 million in 2024, then tumbled by 56.07% to $1.6 million in 2025, then plummeted by 85.97% to $222000.0 in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Shares Issued are $222000.0 (Q1 2026), $1.6 million (Q4 2025), and $1.1 million (Q3 2025).